| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.45 | 0.0004 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.34 | 0.03 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.32 | 0.04 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.32 | 0.08 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.16 | 0.4 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.15 | 0.6 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.04 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.13 | 0.4 |